Nutex Health Inc. NUTX
220.11
15.52
7.59%
as of 25 Sep
- Market cap
- $1.4B
- P/E
- 8.4×
Follow NUTX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
46.57% | 23.13% | 27.64% | 42.63% | |
| 17.19% | 9.00% | 11.21% | 19.93% | ||
ROIC |
37.97% | 32.12% | 31.89% | 37.92% | |
Return on Tangible Assets |
24.60% | 14.89% | 19.66% | 31.89% | |
Average Days of Receivables |
151.35 | 135.71 | 143.48 | 153.76 | |
Free Cash Flow per Share |
26.31 | 38.61 | 38.49 | 39.90 | |
Free Cash Flow |
176.28 | 245.60 | 269.02 | 274.17 | |
Capital Expenditures |
(1.51) | (2.53) | (3.66) | (5.45) | |
Piotroski F-Score |
8.00 | 7.00 | 5.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
19.26% | 27.32% | 28.33% | 27.56% | |
Accounts Receivable Turnover |
4.15 | 3.12 | 2.73 | 2.38 | |
Accounts Payable Turnover |
13.33 | 14.51 | 12.78 | 20.63 | |
Inventory Turnover |
162.97 | 150.80 | 118.58 | 127.33 | |
Average Days of Payables |
40.98 | 41.47 | 39.77 | 8.81 | |
Days of Inventory on Hand |
2.61 | 2.43 | 3.69 | 3.72 | |
Tax Rate |
(0.20) | (0.26) | (0.23) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
18.43% | 19.27% | 16.07% | 8.24% | |
Share Based Compensation of Revenue |
13.68% | 13.37% | 9.71% | 1.13% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.47 | 3.51 | 2.83 | 1.55 | |
Depreciation/Fixed assets |
0.25 | 0.22 | 0.22 | 0.22 | |
Capex/Depreciation |
(0.07) | (0.12) | (0.17) | (0.26) | |
Revenue per Share |
146.42 | 137.59 | 125.89 | 123.23 | |
Operating CF per Share |
26.53 | 39.00 | 39.01 | 40.70 | |
Capex per Share |
(0.23) | (0.40) | (0.52) | (0.79) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | |
Net Profit Margin |
12.29% | 8.09% | 10.95% | 21.25% |
Columns are period end dates